Buy NDC17478-0040-01 Part of Akorn Inc with NSN 6505-01-650-2681
MPN: NDC17478-0040-01
Alternate P/N: NDC17478004001
Manufacturer: Akorn Inc
NSN: 6505-01-650-2681
Item Name: Lorazepam Injection
CAGE Code: 55751
Part number NDC17478-0040-01 is available for immediate shipping. The NSN for part number is 6505016502681. This part is manufactured by Akorn Inc. It is described as Lorazepam Injection. Would you like to request a quote for part number NDC17478-0040-01? Please fill out the form.
The form includes various important fields such as your contact details, Need Parts By, and Quantity. Please make sure to fill out all these fields accordingly before clicking to submit the form. Our experts will review your answers for Need Parts By and Quantity to calculate your quote.

Upload RFQ Sheet
If you have more than one item, upload your spreadsheet here
NSN Information for Part Number NDC17478-0040-01 with NSN 6505-01-650-2681, 6505016502681
NSN | FSC | NIIN | CLS | Hazmat | DEMIL | Cancelled NSN |
---|---|---|---|---|---|---|
6505-01-650-2681 Item Description: Lorazepam Injection | 6505 | 016502681 | M | P | ||
CIIC | HCC | ESD | PMIC | Criticality | ENAC | |
Q | A | 0 | ||||
Part Number | ISC | RNVC | RNCC | HCC | MSDS | SADC |
Ndc17478-0040-01 | 5 | 2 | 3 |
Characteristics Data of NSN 6505-01-650-2681, 6505016502681
MRC | Criteria | Characteristic |
---|---|---|
AJCN | III PROTECTIVE STORAGE FEATURE | REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS |
AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 2.0 MILLIGRAMS LORAZEPAM PER MILLIGRAM |
AKJQ | PHARMACEUTICAL VEHICLE TYPE | AQUEOUS |
CQCT | PRIMARY CONTAINER TYPE | VIAL |
CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 2.0 MILLILITERS |
CRYC | III CONTROLLED SUBSTANCE CLASSIFICATION | SCHEDULE IV |
CSCW | TOTAL PRIMARY CONTAINER QUANTITY | 10 |
CSGS | ADMINISTRATION | INTRAVENOUS AND INTRAMUSCULAR |
CXCY | III PART NAME ASSIGNED BY CONTROLLING AGENCY | ATIVAN INJECTION 2 MG/ML VIAL 1 ML, 10 VIALS PER PACKAGE |
FEAT | SPECIAL FEATURES | LORAZEPAM 2 MG-ML VL 10X1 ML; SCHEDULE IV DEA CONTROLLED SUBSTANCE; INTENDED FOR THE INTRAMUSCULAR OR INTRAVENOUS ROUTES OF ADMINISTRATION; EACH ML OF STERILE INJECTION CONTAINS EITHER 2 MILLIGRAMS OF LORAZEPAM; CONCENTRATION/STRENGTH: 2 MG |
Sought-After NSN Components List
Leading NSN Part Manufacturers